Comparative assessment of the health status of large for gestational age newborns

Our aim was to conduct a comparative assessment of the health status of large for gestational age (LGA) newborns. 348 full-term neonates who were born at the Republican Scientific and Practical Center “Mother and Child” were examined. The main group 1 (Gr1) consisted of 58 LGA newborns from mothers with diabetes mellitus (DM) type 1, the main group 2 (Gr2) consisted of 66 LGA babies from mothers without carbohydrate and lipid metabolism disorders, the main group 3 (Gr3) included 65 LGA babies from mothers with pregravid overweight or obesity, the control group (Gr4) had 159 newborns with the anthropometric parameters corresponding to the gestational age (AGA) from mothers without carbohydrate and lipid metabolism disorders. The negative impact of the mothers’ metabolic disorders on the newborns’ health status, functional state, and neuropsychological development was established. Babies born with macrosomia from mothers with DM were diagnosed with hypoglycemia, congenital pneumonia, hyperbilirubinemia, and neonatal encephalopathy much more often (p < 0.001). LGA babies from obese women were characterized by polycythemia, hyperbilirubinemia, and neonatal encephalopathy. Polycythemia, hyperbilirubinemia, and toxic erythema were often noted in Gr2 patients. The cases of brachial plexus injuries and limb fractures were not registered. A slower rate of neuropsychological development was noted in large neonates in the analyzed groups, and was more pronounced in infants from mothers with diabetes mellitus and obesity. LGA newborns from mothers with DM had a high hospitalization rate at the intensive care unit, followed by the separation of mother and child and a lower breastfeeding rate in the neonatal period. Large newborns from mothers with DM and from women with obesity had a higher probability of adverse neonatal outcomes and a reduced health status in the neonatal period.

1. Modzelewski J., Pokropek A., Jakubiak-Proć M., Muzyka-Placzyńska K., Filipecka-Tyczka D., Kajdy A., Rabijewski M. Large-for-gestational-age or macrosomia as a classifier for risk of adverse perinatal outcome: a retrospective cross-sectional study. Journal of Maternal-Fetal and Neonatal Medicine, 2021, vol. 18, pp. 1‒8. https://doi.org/10.1080/14767058.2021.1887127

2. Ornoy A., Becker M., Weinstein-Fudim L., Ergaz Z. Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with long-term deleterious effects on the offspring. A clinical review. International Journal of Molecular Sciences, 2021, vol. 22, no. 6, art. 2965. https://doi.org/10.3390/ijms22062965

3. Gaudet L., Ferraro Z. M., Wen S. W., Walker M. Maternal obesity and occurrence of fetal macrosomia: a systematic review and meta-analysis. BioMed Research International, 2014, vol. 2014, art. 640291. https://doi.org/10.1155/2014/640291

4. Evsyukova I. I. The impact of maternal obesity and diabetes on fetal brain development (mechanisms and prevention). Zhurnal akusherstva i zhenskikh boleznei = Journal of obstetrics and women’s diseases, 2020, vol. 69, no. 3, pp. 33‒38 (in Russian).

5. Hong Y. H., Lee J. Large for gestational age and obesity-related comorbidities. Journal of Obesity and Metabolic Syndrome, 2021, vol. 30, no. 2, pp. 124‒131. https://doi.org/10.7570/jomes20130

6. The Global Health network. Available at: https://intergrowth21tghn.org/standards-tools/ (accessed 05.06.2021).

7. Devyaltovskaya M. G. Algorithm for assessing psychoneurological disorders in newborn children. Meditsinskaya panorama [Medical panorama], 2008, no. 2, pp. 68‒71 (in Russian).